Terms of ServiceFAQs

© 2020 Unqork™ Inc.     All Rights Reserved

Reimagining Clinical Trials through Digital Transformation

 July 21, 2020  |  12PM ET


Even before COVID-19 prompted an unprecedented rush for new vaccines and treatments, it was clear that many existing clinical trial processes were technologically outmoded. Now that the world is depending on the life sciences industry to find a way out of this pandemic, these operational relics -- with all their inherent inefficiencies -- have become increasingly important to address.

Join as industry expert Kara Dennis provides an overview of how the Unqork platform can help life sciences organizations modernize their clinical trials by using no-code tools to configure tailored, regulatory-compliant applications to organize and manage their trial processes.

Kara Dennis

Head of Healthcare, Unqork

Kara Dennis joined Unqork as Head of Healthcare in 2020, and she leads the company's efforts to deliver innovative no-code enterprise applications to healthcare payers, providers, and life sciences companies. Prior to Unqork, Kara spent the past 9+ years leading teams in healthcare technology, serving as GM for two companies in which she created and commercialized new business lines. Most recently, she was SVP and GM of Clarify Health’s Life Sciences business and head of its NY Office; prior to that she was VP and GM of Mobile Health at Medidata Solutions, an industry-leading provider of SaaS solutions to Life Sciences R&D.

Before Medidata, Kara spent four years in McKinsey's healthcare practice, working on commercial and R&D strategy, M&A, and global public health engagements. She then worked in biotechnology corporate development, where she participated in the evaluation and acquisition of therapies for ICU and NICU settings.

Kara is a frequent speaker on patient engagement in clinical trials and has been interviewed by Bloomberg, NPR, Clinical Leader, The Street, MobiHealthNews and PharmaVOICE, and she has presented and spoken on panels at dozens of industry conferences, including SXSW, DIA, Disruptive Innovations in Trials, FuturePharma, IMPACCT RWE, and many others. She was named to the PharmaVOICE 100 in both 2015 (with Medidata) and 2019 (with Clarify Health) and was highlighted as a Healthcare Businesswomen’s Association Rising Star in 2015. Kara holds an MBA from Harvard Business School, an MA from Columbia University, and a BA from Yale University.

What we'll cover:

  • Building a highly tailored and specific digital workflow for each trial.

  • Supporting remote, decentralized, and hybrid trials with flexible and responsive technology

  • How the Unqork platform can help build robust, secure, enterprise-strength applications with limited overhead and on an approachable timeframe.